antithrombomodulin Search Results



92
Boster Bio cd141
Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and <t>CD141+</t> cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.
Cd141, supplied by Boster Bio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antithrombomodulin/Anti-Thrombomodulin+%2F+CD141+Rabbit+Monoclonal+Antibody/pm36780882-62-45-50
Average 92 stars, based on 1 article reviews
cd141 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
Cymbus Biotechnology anti-thrombomodulin
Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and <t>CD141+</t> cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.
Anti Thrombomodulin, supplied by Cymbus Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antithrombomodulin/anti+thrombomodulin/us08187878-372-7-8
Average 90 stars, based on 1 article reviews
anti-thrombomodulin - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

86
Huabio Inc primary antibodies rabbit polyclonal anti thrombomodulin tm antibody
The summary receiver operating characteristic (ROC) curves of the combination <t>Thrombomodulin</t> (TM), CD64 Index, SOFA Score, and APACHE II Score diagnostic effectiveness analysis for sepsis at 3 different time points. ( A ) The first day, the patient was diagnosed the sepsis (Day 1). ( B ) The third day, the patient was diagnosed the sepsis (Day 3). ( C) The seventh day, the patient was diagnosed the sepsis (Day 7).
Primary Antibodies Rabbit Polyclonal Anti Thrombomodulin Tm Antibody, supplied by Huabio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antithrombomodulin/anti+polyclonal+primary+rabbit+thrombomodulin+tm/pmc12459675-172-0-8
Average 86 stars, based on 1 article reviews
primary antibodies rabbit polyclonal anti thrombomodulin tm antibody - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

N/A
Boster Bio Anti-Thrombomodulin/THBD Antibody Picoband® catalog # A01325-3. Tested in ELISA, Flow Cytometry, IP, IF, IHC, ICC, WB applications. This antibody reacts with Human, Rat. The brand Picoband indicates this is a premium antibody that
  Buy from Supplier

N/A
This is a recombinant monoclonal antibody.
  Buy from Supplier


N/A
Boster Bio Anti-Thrombomodulin THBD Antibody catalog # A01325-2. Tested in WB,IHC,IP applications. This antibody reacts with Human.
  Buy from Supplier

Image Search Results


Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.

Journal: Neuroimmunomodulation

Article Title: Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features.

doi: 10.1159/000529626

Figure Lengend Snippet: Fig. 4. a–c Comparison of circulating dendritic cell subsets in patients with and without anti-AChR antibodies A total of 99 patients accepted the test for anti-AChR IgG antibodies. The circulating levels of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients seropositive for anti-AChR IgG antibodies were compared with those found to be seronegative. As shown, there were no differences in the frequencies of pDCs, CD1c+ cDCs, and CD141+ cDCs in patients with and without anti-AChR antibodies.

Article Snippet: The section was incubated with 10% normal goat serum in phosphate-buffered saline at room temperature, followed by incubation with the primary antibody against CD303 (rabbit antihuman CD303, D161051-0100, Sango Biotech, Shanghai, China), CD1c (mouse anti-human CD1c, TA505384, Zhongshan Jinqiao Biotechnology Co., Ltd, Beijing, China), and CD141 (Rabbit antihuman CD141, BM4158, Boster Biological Technology, Wuhan, China).

Techniques: Comparison

Fig. 5. Comparison of circulating dendritic cell subsets in patients with different MGFA (Myasthenia Gravis Foundation of America) classification as shown, there were no differences in the frequencies of pDCs (a), CD1c+ cDCs (b), and CD141+ cDCs (c) in patients with different MGFA classifications. Notably, patients with IVa and IVb were not included in the comparison because of the small sample size.

Journal: Neuroimmunomodulation

Article Title: Aberrant Dendritic Cell Subsets in Patients with Myasthenia Gravis and Related Clinical Features.

doi: 10.1159/000529626

Figure Lengend Snippet: Fig. 5. Comparison of circulating dendritic cell subsets in patients with different MGFA (Myasthenia Gravis Foundation of America) classification as shown, there were no differences in the frequencies of pDCs (a), CD1c+ cDCs (b), and CD141+ cDCs (c) in patients with different MGFA classifications. Notably, patients with IVa and IVb were not included in the comparison because of the small sample size.

Article Snippet: The section was incubated with 10% normal goat serum in phosphate-buffered saline at room temperature, followed by incubation with the primary antibody against CD303 (rabbit antihuman CD303, D161051-0100, Sango Biotech, Shanghai, China), CD1c (mouse anti-human CD1c, TA505384, Zhongshan Jinqiao Biotechnology Co., Ltd, Beijing, China), and CD141 (Rabbit antihuman CD141, BM4158, Boster Biological Technology, Wuhan, China).

Techniques: Comparison

The summary receiver operating characteristic (ROC) curves of the combination Thrombomodulin (TM), CD64 Index, SOFA Score, and APACHE II Score diagnostic effectiveness analysis for sepsis at 3 different time points. ( A ) The first day, the patient was diagnosed the sepsis (Day 1). ( B ) The third day, the patient was diagnosed the sepsis (Day 3). ( C) The seventh day, the patient was diagnosed the sepsis (Day 7).

Journal: Journal of Inflammation Research

Article Title: Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis

doi: 10.2147/JIR.S535854

Figure Lengend Snippet: The summary receiver operating characteristic (ROC) curves of the combination Thrombomodulin (TM), CD64 Index, SOFA Score, and APACHE II Score diagnostic effectiveness analysis for sepsis at 3 different time points. ( A ) The first day, the patient was diagnosed the sepsis (Day 1). ( B ) The third day, the patient was diagnosed the sepsis (Day 3). ( C) The seventh day, the patient was diagnosed the sepsis (Day 7).

Article Snippet: Primary antibodies - rabbit polyclonal anti-thrombomodulin (TM) antibody (HUABIO, #ET7107-92; 1:500) and mouse monoclonal anti-CD31 antibody (Abcam, # Ab182981 ; 1:200) - were applied to sufficiently cover the tissue and incubated overnight at 4°C.

Techniques: Diagnostic Assay

Expression of plasma Thrombomodulin (TM) in mice in different groups at different time points. ** means p < 0.01, ***means p < 0.001, and ****means p <0.0001 versus in different groups.

Journal: Journal of Inflammation Research

Article Title: Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis

doi: 10.2147/JIR.S535854

Figure Lengend Snippet: Expression of plasma Thrombomodulin (TM) in mice in different groups at different time points. ** means p < 0.01, ***means p < 0.001, and ****means p <0.0001 versus in different groups.

Article Snippet: Primary antibodies - rabbit polyclonal anti-thrombomodulin (TM) antibody (HUABIO, #ET7107-92; 1:500) and mouse monoclonal anti-CD31 antibody (Abcam, # Ab182981 ; 1:200) - were applied to sufficiently cover the tissue and incubated overnight at 4°C.

Techniques: Expressing, Clinical Proteomics

Immunofluorescence analysis of aortic endothelial integrity in septic mice. Immunostaining of mouse aortic sections showing CD31 (endothelial marker, red), thrombomodulin (TM, green), and DAPI (nuclear stain, blue) in Sham-operated (top) versus CLP-induced septic mice (bottom). Merged images demonstrate disrupted endothelial architecture and attenuated TM expression in the CLP group compared to intact endothelium in Sham controls, indicating sepsis-induced vascular injury. Scale bar: 100 μm. CLP: cecal ligation and puncture.

Journal: Journal of Inflammation Research

Article Title: Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis

doi: 10.2147/JIR.S535854

Figure Lengend Snippet: Immunofluorescence analysis of aortic endothelial integrity in septic mice. Immunostaining of mouse aortic sections showing CD31 (endothelial marker, red), thrombomodulin (TM, green), and DAPI (nuclear stain, blue) in Sham-operated (top) versus CLP-induced septic mice (bottom). Merged images demonstrate disrupted endothelial architecture and attenuated TM expression in the CLP group compared to intact endothelium in Sham controls, indicating sepsis-induced vascular injury. Scale bar: 100 μm. CLP: cecal ligation and puncture.

Article Snippet: Primary antibodies - rabbit polyclonal anti-thrombomodulin (TM) antibody (HUABIO, #ET7107-92; 1:500) and mouse monoclonal anti-CD31 antibody (Abcam, # Ab182981 ; 1:200) - were applied to sufficiently cover the tissue and incubated overnight at 4°C.

Techniques: Immunofluorescence, Immunostaining, Marker, Staining, Expressing, Ligation

Expression of Thrombomodulin (TM) in aortic endothelial. ( A ) Expression efficiency of TM by quantitative real-time polymerase chain reaction (qRT-PCR). ( B ) Expression efficiency of TM by Western Blot. ( C ) Quantitated by densitometric analysis (n=6). ***means p < 0.001, and ****means p <0.0001 versus in different groups.

Journal: Journal of Inflammation Research

Article Title: Endothelial Injury-Induced Shedding of Thrombomodulin as a Biomarker for Predicting Adverse Prognosis in Sepsis

doi: 10.2147/JIR.S535854

Figure Lengend Snippet: Expression of Thrombomodulin (TM) in aortic endothelial. ( A ) Expression efficiency of TM by quantitative real-time polymerase chain reaction (qRT-PCR). ( B ) Expression efficiency of TM by Western Blot. ( C ) Quantitated by densitometric analysis (n=6). ***means p < 0.001, and ****means p <0.0001 versus in different groups.

Article Snippet: Primary antibodies - rabbit polyclonal anti-thrombomodulin (TM) antibody (HUABIO, #ET7107-92; 1:500) and mouse monoclonal anti-CD31 antibody (Abcam, # Ab182981 ; 1:200) - were applied to sufficiently cover the tissue and incubated overnight at 4°C.

Techniques: Expressing, Real-time Polymerase Chain Reaction, Quantitative RT-PCR, Western Blot